* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download CB064-4.15
Heart failure wikipedia , lookup
Jatene procedure wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Cardiac surgery wikipedia , lookup
Coronary artery disease wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Cardiovascular Diseases and Related Medications NSG 106 Pharmacotherapeutics Six Cardinal Signs of Heart Failure Dyspnea Chest Pain Fatigue Edema Syncope or near-syncope Palpitations Treatment of Heart Failure Combination of vasodilator, inotropic, and diuretic therapies Vasodilators reduce Left Ventricular strain = reduced peripheral resistance against which the LV must pump (I.e., reduces “afterload”) Vasodilators also reduce “preload”. • the volume of blood returning to the right side of heart is decreased. This decreases pulmonary congestion and decreases SOB. • Example – IV Nitro gtt (critical pt) • Example – ACE Inhibitors, possibly Beta blockers if no severe respiratory compromise Treatment of Heart Failure Inotropic agents stimulate the heart to increase the force of contraction, making cardiac output more efficient, which improves overall tissue and organ perfusion Example: Digoxin Diuretics are administered after renal perfusion is improved, to further enhance sodium and water excretion. Example: Loop diuretics – Lasix, Bumex Digitalis Glycosides Definition These drugs (Prototype-digoxin) have 2 primary actions in the treatment of heart failure/arrhythmias • Positive Inotrope Increases force of heart’s contraction • Negative chronotrope Slows the heart rate Purpose These actions allow the “pump” to work more effectively by filling and emptying more completely w/each beat Treatment CHF, afib/flutter, other atrial arrhythmias Digoxin (Lanoxin) Loading dose to “digitalize” the patient over 24-48 hrs, then – Maintenance dose, usu. QD To achieve optimum Cardiac Output, heart rate, and relief of CHF symptoms • Usu. will take med the rest of their life Digoxin most commonly used, IV or p.o. Not the same as digitoxin Digoxin Implementation Take apical pulse one full minute before administration • Adult: DO NOT administer if apical pulse is < 60 • Peds: DO NOT administer if apical pulse is < 90 Consult w/MD before administering drug Monitor for S/S of dig. toxicity • Lab results for digoxin levels • N/V, bradycardia, visual/psych disturbances • If toxic, expect orders to stop digoxin and any K+-depleting diuretics Digibind IV (antidote if severely toxic) Therapeutic Outcomes Improved Cardiac Output, resulting in improved tissue perfusion and tolerance to activity Antiarrhythmics •Classified according to their effects on the electrical conduction system of the heart. • Therapeutic Outcome: Normal Sinus Rhythm Antiarrhythmics Myocardial depressants inhibit NA+ ion movement in cardiac muscle (“anesthetize” the muscle in an effort to stop the arrhythmia) Example: Lidocaine Treat ventricular arrhythmias which can be life-threatening, e.g., vtach, v-fib Make sure you have lidocaine WITHOUT PRESERVATIVES OR EPINEPHRINE! Lidocaine with preservatives and/or epi are used to inject locally for an anesthetic. S.E.’s: restlessness, muscle twitching, seizures Antiarrhythmics Slow the rate of electrical conduction Prolongs time between contractions Example: Amiodarone (Cordarone) IV/p.o. Treats ventricular, supraventricular arrhythmias, afib/flutter Many side effects • Fatigue, tremors, sleep disturbance, ataxia, dizziness, exertional dyspnea, cough, blurred vision, N/V, constipation, anorexia, photosensitivity, hepatotoxicity • Increases serum levels of digitalis glycosides, coumadin, dilantin, theophylline – MONITOR! Anti-Anginals Definition Angina pectoris is chest discomfort resulting from the heart muscle’s lack of adequate 02 perfusion, typically due to coronary artery disease (CAD) of the vessels which perfuse the heart muscle. Purpose To decrease the oxygen demand of the heart muscle by decreasing heart rate, myocardial contractility, and ventricular volume. Platelet aggregation, blood flow turbulence, and blood viscosity also play a role in coronary circulation. Therefore, platelet-active agents are included in the discussion. Anti-Anginals Nitrates Calcium Channel Blockers Beta Blockers Platelet-Active Agents Therapeutic Outcome: Relief of chest discomfort and improved ability to tolerate physical activity Nitrates Nitroglycerin (Nitrostat) Produces potent peripheral vasodilatation and coronary artery dilatation, enhancing 02 supply to ischemic heart muscle. Delivery: sublingual (tab), topical (paste), translingual (spray), transdermal (patch), or IV For chest pain (CP) • SL tab or spray dose q 5 minutes x 3 to relief of CP, • monitoring BP and pulse before each successive dose. Have pt sit or lie down; assist to trendelenberg if lightheaded or low BP. • IV site in place before hand, in case fluid administration is needed to raise BP. If unrelieved, alert MD. Nitrates Side Effects: Headache (usu. transient, ~5 - 20 mins) Excessive hypotension • May need to place in Trendelenberg and/or IV fluids if nearsyncope. Dizziness, flushing, nausea (usu. transient) Interactions Avoid alcohol, other CNS depressants unless prescribed; do NOT use concurrently w/Viagra Platelet-Active Agents Hemorrheologic Agents Definition • Increases erythrocyte flexibility, decreases fibrinogen, and prevents aggregation of RBC’s and platelets. Purpose • Decreases viscosity of blood and improves flow properties, resulting in increased blood flow to affected areas, thereby enhancing tissue oxygenation Platelet-Active Agents Pentoxifylline (Trental) • Treatment Peripheral vascular disease Intermittent claudication • Side Effects: GI upset (dyspepsia) Give w/ food HA, dizziness Monitor for pt. safety with initial doses Therapeutic Outcome • Improved tissue perfusion and peripheral pulses; improved activity tolerance Platelet-Active Agents Platelet Aggregation Inhibitors Definition • Increases levels of cAMP, resulting in vasodilatation and inhibition of platelet aggregation (tendency of platelets to clump together). Purpose • By improving vasodilatation and decreasing platelet aggregation, symptoms of peripheral vascular disease should improve. Platelet-Active Agents Cilostazol (Pletal) Treatment • PVD, e.g., intermittent claudication Tx should also include smoking cessation, weight loss, surgical intervention if necessary Side Effects • Dyspepsia, diarrhea • HA, dizziness Adverse Effect • NOT to be given to CHF patients • Anti-fungals, diltiazem, and grapefruit juice can inhibit the metabolism of this drug - dose should be halved if taking any of these concurrently. Hypertension High blood pressure puts a strain on the heart and the arteries. People with high blood pressure are also at higher risk for MI and CVA. Controlling high blood pressure makes these problems less likely. Hypertension and the JNC-7 Guidelines Ten years ago, the therapeutic goal in patients with high blood pressure was a BP of less than 140/90 mm Hg. In 2003, the seventh report of the Joint Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII) appropriately assigned patients with pressures of 120139 systolic, and 80-89 diastolic as prehypertensive, and requiring treatment with life style modifications. See pg 642 Hypertension and the JNC-7 Guidelines According to the JNC-VII evidence-based guidelines: Note that lifestyle modification is #1 step, then on to a thiazide diuretic as the initial treatment. Begin with once daily, low dosing. • If control not controlled in 3 months, dose can be increased, or a different BP med may be prescribed, or a second drug from a different class may be added. Therapy with antihypertensive agents from a multiplicity of drug classes with diverse pharmacologic effects (diuretics, beta blockers, calcium antagonists and angiotensin-converting enzyme inhibitors) reduces blood pressure-related disease and death. Alpha1-adrenergic blockers Definition Alpha1-adrenergic blockers are drugs that work by producing arteriolar and venous vasodilatation, thus reducing peripheral vascular resistance. Purpose These drugs, called alpha blockers for short, are used for two main purposes: to treat high blood pressure (hypertension) and to treat benign prostatic hyperplasia (BPH), a condition in men in which the prostate gland enlarges, impeding urine flow. Alpha1-adrenergic blockers doxazosin mesylate (Cardura) and terazosin HCl (Hytrin) May make blood pressure drop too low = dizziness, lightheadedness, palpitations, and fainting. Additive effect with diuretics and beta blockers Pt. Teaching Do not abruptly stop taking this medication. Should begin with a low dose and take w/food. Watch for additive effects: Teach safety - Lie down if above symptoms occur. Therapeutic Outcomes Reduction of BP and/or Angiotensin-Converting Enzyme Inhibitors (ACE) Definition ACE inhibitors are medicines that block the conversion of the chemical angiotensin I to angiotensin II, a reaction that would increase salt and water retention in the body. • Therefore, there is a diuretic effect with use of ACE inhibitors. Purpose ACE inhibitors may be used alone or in combination with other BP meds. Promising approach to slowing nephropathy in patients with type 2 diabetes ACE Inhibitors Captopril (Capoten), enalapril maleate (Vasotec), lisinopril (Prinivil, Zestril) “First dose faint” potential w/initial dose, esp. if concurrent use of diuretics (not an indicator to stop therapy) Fetotoxic during pregnancy! Other Side Effects Potential for hyperkalemia (aldosterone is inhibited); chronic cough; nephrotoxicity; neutropenia Pt Teaching Postural hypotension measures Importance of lab work for at risk re: kidney function, low WBC counts, hyperkalemia Beta blockers Definition Beta blockers inhibit the cardiac response to sympathetic nerve impulses. This, in turn, decreases the force and rate of the heart's contractions, which lowers blood pressure and reduces the heart's demand for oxygen. Purpose Used to treat high blood pressure, angina, cardiac arrhythmias, and acute MI Reduction of morbidity and mortality from MI and HTN has been shown. • They may also be prescribed for migraines, tremors, and “stage fright”. • In eye drop form, they are used to treat certain kinds of glaucoma. Beta Blockers Atenolol (Tenormin), metoprolol (Lopressor), labetolol (Normodyne) Side effects: (lungs) Beta 1=heart; Beta 2=bronchi (lungs) Bradycardia Bronchospasm (esp. if nonselective beta drug, e.g., labetolol) CardioSelective Bblockers (block Beta 1 only) include atenolol, metoprolol – better for pts with respiratory conditions, CHF • However, any of these in larger doses impact beta2 receptors, and thus use w/caution in pts who have respiratory compromise or CHF hx. Hypoglycemia - S/S can be masked Heart failure - monitor for increase in edema, dyspnea Beta Blockers Side Effects, continued Additive effect with other anti-HTN’s Prostaglandin inhibitors such as NSAIDS can inhibit Bblocker activity Pt. Teaching • Do not discontinue drug abruptly Side Effects usually just need dosage adjustment • If drug dc’d, must do so gradually, per MD order Pt.s have experienced angina and subsequent MI after an abrupt d/c Therapeutic Outcome Reduction in BP, angina, cardiac arrhythmias Reduction in ocular pressure re: eye gtts Disclaimer This workforce solution was funded by a grant awarded under the President’s Community-Based Job Training Grants as implemented by the U.S. Department of Labor’s Employment and Training Administration. The solution was created by the grantee and does not necessarily reflect the official position of the U.S. Department of Labor. The Department of Labor makes no guarantees, warranties, or assurances of any kind, express or implied, with respect to such information, including any information on linked sites and including, but not limited to, accuracy of the information or its completeness, timeliness, usefulness, adequacy, continued availability, or ownership. This solution is copyrighted by the institution that created it. Internal use by an organization and/or personal use by an individual for non-commercial purposes is permissible. All other uses require the prior authorization of the copyright owner. Calcium Channel Blockers Definition Calcium channel blockers are medicines that slow the movement of calcium into the cells of the heart and blood vessels. This, in turn, relaxes blood vessels, increases the supply of oxygen-rich blood to the heart, and reduces the heart's workload. Purpose Used to treat high blood pressure, abnormal heart rhythms (e.g., Cardizem gtt for afib), and angina pectoris. They may also be prescribed to treat panic attacks, bipolar disorder, and migraine headache. Calcium Channel Blockers Amlopidine (Norvasc), diltiazem HCl (Cardizem), and verapamil (Calan SR, Isoptin SR). Side Effects: Hypotension and syncope possible in first week. • Dizziness, lightheadedness, flushing, headache, and nausea, usually go away as the body adjusts to the drug and do not require medical treatment unless symptoms persist or they are bothersome. Edema • Is the heart being slowed too much? – CHF Constipation Calcium Channel Blockers Additive effect with diuretics and other antihypertensives Increases serum levels of digitalis, some antiseizure meds, and blood glucose – monitor labs accordingly Pt. Teaching Do not abruptly stop taking this medication. Should begin with a lower dose and take w/food. Watch for additive effects: Teach safety – sit or lie down if orthostatic hypotension occurs. Therapeutic Outcomes Reduction of BP and/or irregular heart rhythm, angina pectoris Centrally-acting Alpha-2 Agonists Definition The action of centrally acting alpha-2 agonists reduces sympathetic nerve outflow from the brain and CNS, thus decreasing peripheral vascular resistance and slowing the heart rate, thereby reducing BP. Investigational use for ADHD Purpose Reduction in blood pressure. Reduction in attention deficit and hyperactivity Centrally-acting Alpha-2 Agonists Clonidine HCl (Catapres) Side Effects: Sedation, dry mouth, dizziness, constipation • Usually self-limiting • Do NOT d/c drug abruptly Rebound effect may occur with rapid increase in BP, agitation, tremors, HA, nausea Depression • Assess affect and overall cognitive behavior before beginning this medication, and continue to monitor for behavioral changes/complaints. Transdermal application • Contact dermatitis in 10-15%; consider p.o./SL Centrally-acting Alpha-2 Agonists Cumulative effects with other anti-HTN’s and digitalis Monitor closely for cumulative effects • Blood levels, medication regimen, OTC’s, alcohol, sedative use Pt. Teaching Do NOT d/c abruptly: D/C over 2-4 days per order Do not drink alcohol while on this medication Do not use other sedatives without MD prescription Be alert for signs of depression, esp. if previous hx Direct Vasodilators Definition Vasodilators act directly on muscles in blood vessel walls to make blood vessels dilate. Purpose Through arterial and/or venous vasodilation, these drugs reduce blood pressure. Vasodilators usually are prescribed with other types of blood pressure drugs and rarely are used alone. Direct Vasodilators hydralazine HCl (Apresoline) Causes arterial vasodilatation (reduces after load) • However, this action causes a reflex INCREASE in HR, cardiac output, and renin (Kidneys) release, causing sodium and H20 retention. • Therefore, this pt should also be taking a sympathetic inhibitor like a Beta blocker and a diuretic to counter these effects. Used to treat Stage 2 & 3 HTN, and HTN assoc. with renal disease and toxemia of pregnancy sodium nitroprusside (Nipride)(IV only) Arterial and venous vasodilatation • Reduces preload and after load • Used in hypertensive crisis, severe CHF in ICU Direct Vasodilators Side Effects: Headache Tachycardia, palpitations (hydralazine if used alone) Nausea or vomiting Diarrhea Loss of appetite Orthostatic hypotension Additive effects with other anti-HTN’s and diuretics-monitor closely